Shattil S J, Motulsky H J, Insel P A, Flaherty L, Brass L F
Blood. 1986 Dec;68(6):1224-31.
Epinephrine causes platelet aggregation and secretion by interacting with alpha 2-adrenergic receptors on the platelet surface. Platelet aggregation requires the binding of fibrinogen to a specific receptor on the membrane glycoprotein IIb-IIIa complex. Although the IIb-IIIa complex is identifiable on the surface of resting platelets, the fibrinogen receptor is expressed only after platelet activation. The current studies were designed to examine the effect of occupancy of platelet alpha 2-adrenergic receptors by epinephrine on the expression of fibrinogen receptors and on the aggregation of platelets. The ability of epinephrine to induce the expression of fibrinogen receptors was studied under two different conditions: acute stimulation (less than 1 min) and prolonged stimulation (50 to 90 min), the latter of which is associated with a reduction or "desensitization" of the platelet aggregation response. Expression of the fibrinogen receptor was monitored with 125I-fibrinogen as well as with 125I-PAC-1 (PAC-1), a monoclonal antibody that binds to the glycoprotein IIb-IIIa complex only after platelets are activated. Epinephrine caused an immediate increase in PAC-1 and fibrinogen binding that was dependent on occupancy of the alpha 2-receptor by epinephrine and on the presence of extracellular free Ca (KCa = 30 mumol/L). By itself, 1 mmol/L Mg was unable to support induction of the fibrinogen receptor by epinephrine. However, it did decrease the Ca requirement by about two orders of magnitude. Prolonged stimulation of unstirred platelets by epinephrine led to a 70% decrease in the aggregation response when the platelets were subsequently stirred. Despite their decreased aggregation response, desensitized platelets bound PAC-1 and fibrinogen normally, indicating that the loss of aggregation was not due simply to a decrease in fibrinogen receptor expression. Although desensitization was not affected by pretreatment of the platelets with aspirin, it was partially prevented when extracellular Ca was chelated by EDTA during the long incubation with epinephrine. These studies demonstrate that once platelet alpha 2-adrenergic receptors are occupied by epinephrine, extracellular Ca is involved in initiating the aggregation response by supporting the induction of the fibrinogen receptor and the binding of fibrinogen. Furthermore. Ca-dependent reactions subsequent to fibrinogen binding may be necessary for maximal platelet aggregation and are impaired when platelets become desensitized to epinephrine.
肾上腺素通过与血小板表面的α2 - 肾上腺素能受体相互作用,引起血小板聚集和分泌。血小板聚集需要纤维蛋白原与膜糖蛋白IIb - IIIa复合物上的特定受体结合。虽然在静息血小板表面可识别出IIb - IIIa复合物,但纤维蛋白原受体仅在血小板活化后才表达。当前的研究旨在探讨肾上腺素占据血小板α2 - 肾上腺素能受体对纤维蛋白原受体表达和血小板聚集的影响。在两种不同条件下研究了肾上腺素诱导纤维蛋白原受体表达的能力:急性刺激(小于1分钟)和延长刺激(50至90分钟),后者与血小板聚集反应的降低或“脱敏”有关。用125I - 纤维蛋白原以及125I - PAC - 1(PAC - 1)监测纤维蛋白原受体的表达,PAC - 1是一种单克隆抗体,仅在血小板活化后才与糖蛋白IIb - IIIa复合物结合。肾上腺素导致PAC - 1和纤维蛋白原结合立即增加,这取决于肾上腺素对α2受体的占据以及细胞外游离钙的存在(KCa = 30 μmol/L)。单独的1 mmol/L Mg不能支持肾上腺素诱导纤维蛋白原受体。然而,它确实使钙需求降低了约两个数量级。当随后搅拌血小板时,肾上腺素对未搅拌血小板的延长刺激导致聚集反应降低70%。尽管脱敏血小板的聚集反应降低,但它们正常结合PAC - 1和纤维蛋白原,表明聚集的丧失并非仅仅由于纤维蛋白原受体表达的降低。虽然脱敏不受血小板用阿司匹林预处理的影响,但当在与肾上腺素的长时间孵育期间用EDTA螯合细胞外钙时,部分可防止脱敏。这些研究表明,一旦血小板α2 - 肾上腺素能受体被肾上腺素占据,细胞外钙通过支持纤维蛋白原受体的诱导和纤维蛋白原的结合参与启动聚集反应。此外,纤维蛋白原结合后的钙依赖性反应可能是最大血小板聚集所必需的,并且当血小板对肾上腺素脱敏时会受损。